Letter/Comment
The latest advocacy letters and comments from the American Hospital Association.
Docket No. FDA-2014-D-1525: Mixing, Diluting, or Repackaging Biological Products Outside the Scope of an Approved Biologics License Application; Draft Guidance for Industry